FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Harland

Research Profile

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Rosalyn Jewell; Jon Laye; Angana Mitra; Andy Boon; Philip Chambers; Caroline Conway; Martin G Cook; Faye Elliott; Mark Harland; Julia Newton-Bishop
Clinicopathologic features of V600E and V600K melanoma--letter.
John R Davies; Zaida García-Casado; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Veronica Höiom; Peter Kanetsky; Kairen Kukalizch; Rajiv Kumar; Srinivasan Madhusudan; Eduardo Nagore; Zighereda Ogbah; Ichiro Okamoto; Aija Ozola; Dace Pjanova; Susana Puig; Paola Queirolo; Juliette A Randerson-Moor; philippe saiag; Dirk Schadendorf; Nadem Soufir; Antje Sucker; Remco van Doorn; Judith Wendt; Paul Affleck; Jennifer H Barrett; D Timothy Bishop; Julia Newton-Bishop
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.
John R Davies; Faye Elliott; Mark Harland; Sue Haynes; Peter Kanetsky; Birute Karpavicius; Kairen Kukalizch; Susan Leake; Jennifer H Barrett; Julian Barth; D Timothy Bishop; May Chan; Yu-Mei Chang; Juliette A Randerson-Moor; HM Snowden; Julia Newton-Bishop
The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Harland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rosalyn Jewell; Jon Laye; Angana Mitra; Andy Boon; Philip Chambers; Caroline Conway; Martin G Cook; Faye Elliott; Mark Harland; Julia Newton-Bishop
Clinicopathologic features of V600E and V600K melanoma--letter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(24):6792; author's reply p. 6793.
2012: John R Davies; Zaida García-Casado; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Veronica Höiom; Peter Kanetsky; Kairen Kukalizch; Rajiv Kumar; Srinivasan Madhusudan; Eduardo Nagore; Zighereda Ogbah; Ichiro Okamoto; Aija Ozola; Dace Pjanova; Susana Puig; Paola Queirolo; Juliette A Randerson-Moor; philippe saiag; Dirk Schadendorf; Nadem Soufir; Antje Sucker; Remco van Doorn; Judith Wendt; Paul Affleck; Jennifer H Barrett; D Timothy Bishop; Julia Newton-Bishop
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.
Pigment cell & melanoma research 2012;25(3):384-94.
2011: John R Davies; Faye Elliott; Mark Harland; Sue Haynes; Peter Kanetsky; Birute Karpavicius; Kairen Kukalizch; Susan Leake; Jennifer H Barrett; Julian Barth; D Timothy Bishop; May Chan; Yu-Mei Chang; Juliette A Randerson-Moor; HM Snowden; Julia Newton-Bishop
The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.
Cancer causes & control : CCC 2011;22(10):1471-82.
2008: Mark Harland; Alisa M Goldstein; Kairen Kukalizch; Claire Taylor; David Hogg; Susana Puig; Celia Badenas; Nelleke Gruis; Jeanet ter Huurne; Wilma Bergman; Nicholas K Hayward; Mitchell Stark; Hensin Tsao; Margaret A Tucker; Maria Teresa Landi; Giovanna Bianchi Scarra; Paola Ghiorzo; Peter Kanetsky; David E Elder; Graham J Mann; Elizabeth A Holland; D Timothy Bishop; Julia Newton Bishop
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).
European journal of cancer (Oxford, England : 1990) 2008;44(9):1269-74.
2007: Dace Pjanova; Ludmila Engele; Juliette A Randerson-Moor; Mark Harland; D Timothy Bishop; Julia Newton-Bishop; Claire Taylor; Tadeusz Debniak; Jan Lubinski; Regina Kleina; Olita Heisele
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
Melanoma research 2007;17(3):185-91.
2007: Julia Newton Bishop; Mark Harland; Juliette A Randerson-Moor; D Timothy Bishop
Management of familial melanoma.
The lancet oncology 2007;8(1):46-54.
2006: Julia Newton Bishop; Mark Harland; D Timothy Bishop
The genetics of melanoma.
British journal of hospital medicine (London, England : 2005) 2006;67(6):299-304.
2005: Sushila H Mistry; Claire Taylor; Juliette A Randerson-Moor; Mark Harland; Faye Turner; Jennifer H Barrett; Linda Whitaker; Robert B Jenkins; Margaret A Knowles; Julia Newton-Bishop; D Timothy Bishop
Prevalence of 9p21 deletions in UK melanoma families.
Genes, chromosomes & cancer 2005;44(3):292-300.
2005: Mark Harland; Claire F Taylor; Philip A Chambers; Kairen Kukalizch; Juliette A Randerson-Moor; Nelleke A Gruis; Femke A De Snoo; Jeanet A C ter Huurne; Alisa M Goldstein; Margaret A Tucker; D Timothy Bishop; Julia Newton-Bishop
A mutation hotspot at the p14ARF splice site.
Oncogene 2005;24(28):4604-8.
2005: Mark Harland; Claire F Taylor; Sylvia Bass; Michael Churchman; Juliette A Randerson-Moor; Elizabeth A Holland; Graham J Mann; D Timothy Bishop; Julia Newton-Bishop
Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.
Genes, chromosomes & cancer 2005;43(2):128-36.
2005: Sharon Jackson; Mark Harland; Faye Turner; Claire Taylor; Philip A Chambers; Juliette A Randerson-Moor; Anthony J Swerdlow; Isabel dos Santos Silva; Samantha Beswick; D Timothy Bishop; Julia Newton-Bishop
No Evidence for BRAF as a melanoma/nevus susceptibility gene.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):913-8.
2002: Thomas J G Huot; Janice Rowe; Mark Harland; Sarah Drayton; Sharon Brookes; Chandra Gooptu; Patricia Purkis; Mike Fried; Veronique Bataille; Eiji Hara; Julia Newton-Bishop; Gordon Peters
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Molecular and cellular biology 2002;22(23):8135-43.
2002: D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac De-Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Journal of the National Cancer Institute 2002;94(12):894-903.
2001: Mark Harland; S Mistry; D Timothy Bishop; Julia Newton-Bishop
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees.
Human molecular genetics 2001;10(23):2679-86.
2001: Juliette A Randerson-Moor; Mark Harland; S Williams; Darren Cuthbert-Heavens; E Sheridan; J Aveyard; Kathryn D Sibley; Linda Whitaker; M Knowles; Julia Newton Bishop; D Timothy Bishop
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
Human molecular genetics 2001;10(1):55-62.
2000: Mark Harland; Elizabeth A Holland; Paola Ghiorzo; Michela Mantelli; Giovanna Bianchi-Scarrà; Alisa M Goldstein; Margaret A Tucker; bruce ponder; Graham J Mann; D Timothy Bishop; Julia Newton-Bishop
Mutation screening of the CDKN2A promoter in melanoma families.
Genes, chromosomes & cancer 2000;28(1):45-57.
2000: Julia Newton-Bishop; Rachel C Wachsmuth; Mark Harland; Veronique Bataille; Elizabeth Pinney; P MacK; Laura Baglietto; Jack Cuzick; D Timothy Bishop
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
The Journal of investigative dermatology 2000;114(1):28-33.
1999: Julia Newton-Bishop; Mark Harland; Dorothy C Bennett; Veronique Bataille; Alisa M Goldstein; Margaret A Tucker; bruce ponder; Jack Cuzick; P Selby; D Timothy Bishop
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
British journal of cancer 1999;80(1-2):295-300.
1998: Rachel C Wachsmuth; Mark Harland; Julia Newton-Bishop
The atypical-mole syndrome and predisposition to melanoma.
The New England journal of medicine 1998;339(5):348-9.
1998: Julia Newton-Bishop; Mark Harland; Tim BISHOP
The genetics of melanoma: the UK experience.
Clinical and experimental dermatology 1998;23(4):158-61.
1997: Mark Harland; R Meloni; Nelleke A Gruis; Elizabeth Pinney; Sharon Brookes; N K Spurr; AM Frischauf; Veronique Bataille; Gordon Peters; Jack Cuzick; P Selby; D Timothy Bishop; Julia Newton Bishop
Germline mutations of the CDKN2 gene in UK melanoma families.
Human molecular genetics 1997;6(12):2061-7.